Precision Health Clinical Trials

Action of the Vidaza on the Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Acute Leukemia
Intervention:   Other: Effect of Vidaza treatment
Sponsor:   Hospices Civils de Lyon
Recruiting

the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment

Condition:   Triple Negative Breast Cancer
Interventions:   Drug: Vinorelbine Tartrate;   Drug: Capecitabine 500 MG
Sponsor:   Mario Negri Institute for Pharmacological Research
Recruiting

A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients

Condition:   Non-small Cell Lung Cancer
Intervention:   Drug: pembrolizumab
Sponsors:   Sichuan University;   Geneplus-Beijing Co. Ltd.
Recruiting

Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy

Conditions:   Colorectal Cancer;   Colorectal Cancer Metastatic;   Hepatic Metastases
Intervention:  
Sponsors:   University Health Network, Toronto;   Terry Fox Research Institute;   British Columbia Cancer Agency
Recruiting

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

Condition:   Biliary Cirrhosis, Primary
Intervention:  
Sponsor:   Target PharmaSolutions, Inc.
Recruiting

The Circulating Cell-free Genome Atlas Study

Conditions:   Neoplasms;   Cancer
Intervention:  
Sponsor:   GRAIL, Inc.
Recruiting

Pharmacogenomics of Warfarin in Hispanics and Latinos

Conditions:   Thrombosis;   Hemorrhage
Interventions:   Procedure: Mouthwash sample;   Procedure: Blood Draw
Sponsor:   University of Arizona
Recruiting

Expanded Noninvasive Genomic Medical Assessment: The Enigma Study

Conditions:   Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Klinefelter Syndrome;   Turner Syndrome;   DiGeorge Syndrome;   Chromosome Deletion;   Aneuploidy
Intervention:   Other: Blood sampling for Laboratory Developed Test (LDT) analysis
Sponsor:   Progenity, Inc.
Recruiting

Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis

Conditions:   Glioblastoma;   Brain Metastases
Intervention:   Drug: ceritinib 750mg
Sponsors:   St. Joseph's Hospital and Medical Center, Phoenix;   Novartis;   Wayne State University;   Translational Genomics Research Institute
Recruiting

Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Conditions:   Adult B Acute Lymphoblastic Leukemia;   Adult T Acute Lymphoblastic Leukemia;   Childhood B Acute Lymphoblastic Leukemia;   Childhood T Acute Lymphoblastic Leukemia;   Untreated Adult Acute Lymphoblastic Leukemia;   Untreated Childhood Acute Lymphoblastic Leukemia
Interventions:   Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
Recruiting

Pages